Clinical Trial Update: A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and potential clinical benefit of MultiStem in adults with moderate to severe ulcerative colitis has completed and posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• MultiStem (mesenchymal-like stem cell product)

Snippet

Sponsor: Pfizer | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2016-02-23